Need Help?

Longitudinal tracking of CRC patients

Heatrich-BS was performed on 14 patients monitored across 5-8 timepoints each. The predicted tumor fraction trend was compared with CEA values and tumor measurements from CT scans.

Request Access

Policy for processing data access request

Policy for processing data access requests This policy describes how the NUS cfDNA Data Access Committee (DAC) will process requests for datasets stored in the European Genome-phenome Archive (EGA), when those datasets are made available by manuscripts that specifically reference this policy. Purpose 1. To ensure that applicants are qualified investigators, affiliated with an academic, non- profit, or government research organization. 2. To ensure that users of the data agree to comply with applicable laws, including requirements as outlined in any governing consent and appropriate ethical approvals, along with any restrictions for the data in question. General principles Introduction The DAC will consider applications for access to datasets stored in the EGA when authorized to do so in accordance with this policy. Access to data will be granted to qualified researchers for appropriate use. A qualified researcher refers to a scientist who is employed, or legitimately affiliated with an academic, non-profit, or government research organization. Access to data will be granted to researchers for appropriate use and will be governed by the provisions and terms contained in the Data Access Agreement and consistent with an informed consent (if applicable). The DAC is concerned only with access to the data stored within the EGA with this DAC as the designated data access committee. Access is conditional upon availability of data and a signed agreement governing issues related to publication, data use, data storage, data disposal, ethical approval, and confidentiality. Application procedure To request access to data from the EGA, you will be asked to complete a basic application form and to agree to the terms and conditions laid out in the Data Access Agreement (DAA). The DAA must be signed by both a representative with institutional authority to sign on behalf of your organization, and the principal investigator responsible for the research project. You will also be requested to list personnel who will be granted access to the data for the purposes of the research project. If your application is successful, you will be asked to designate a “registered user”, under the authority of the principal investigator, who will be issued with a username and password by the EGA to enable access to the database. The DAC will consider applications that include named collaborators, but each institution must sign a separate DAA. Should you wish to share the data with additional collaborators not previously approved, they must make a separate application for access to the data. You agree to use the data only for the approved purpose and project described in your application; use of the data for a new purpose or new or expanded project will require a new application and approval. Assessment criteria Each application will be assessed to determine if: ● it has been submitted by a qualified researcher or researchers, embedded in a recognized research institution that can provide institutional responsibility for appropriate research governance ● the project described constitutes “biomedical research” in the context of the consent process, and is likely to be understood as such by the sample donors ● it breaches any of the ethical permissions or restrictions in the consent forms for any component cohort or collection The DAC will use these practices in its assessment: ● The DAC explicitly does NOT attempt to peer review the scientific quality of proposals. However, it does ask for a brief summary of the research to be undertaken, in order to judge whether it falls within the scope of the consents. Reporting The DAC may periodically report publicly on the requests received and their disposition, including reasons for access refusal. Acknowledgments Purpose adapted from the Blueprint Data Access Committee Terms of Reference. General principles adapted from the Blueprint Data Access Committee General Principles.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001006198 Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00006143484 fq.gz 415.3 MB
EGAF00006143485 fq.gz 404.0 MB
EGAF00006143486 fq.gz 81.7 MB
EGAF00006143487 fq.gz 78.1 MB
EGAF00006143488 fq.gz 186.6 MB
EGAF00006143489 fq.gz 175.2 MB
EGAF00006143490 fq.gz 362.5 MB
EGAF00006143491 fq.gz 338.6 MB
EGAF00006143494 fq.gz 204.3 MB
EGAF00006143495 fq.gz 190.5 MB
EGAF00006143496 fq.gz 263.0 MB
EGAF00006143497 fq.gz 247.3 MB
EGAF00006143498 fq.gz 231.3 MB
EGAF00006143499 fq.gz 218.1 MB
EGAF00006143500 fq.gz 291.3 MB
EGAF00006143501 fq.gz 265.7 MB
EGAF00006143502 fq.gz 209.0 MB
EGAF00006143503 fq.gz 194.3 MB
EGAF00006143504 fq.gz 337.7 MB
EGAF00006143505 fq.gz 314.1 MB
EGAF00006143506 fq.gz 101.7 MB
EGAF00006143507 fq.gz 94.8 MB
EGAF00006143508 fq.gz 385.1 MB
EGAF00006143509 fq.gz 355.7 MB
EGAF00006143510 fq.gz 246.8 MB
EGAF00006143511 fq.gz 237.4 MB
EGAF00006143516 fastq.gz 174.4 MB
EGAF00006143517 fastq.gz 193.8 MB
EGAF00006143518 fq.gz 419.4 MB
EGAF00006143519 fq.gz 392.5 MB
EGAF00006143520 fastq.gz 234.4 MB
EGAF00006143521 fastq.gz 255.8 MB
EGAF00006143522 fq.gz 187.1 MB
EGAF00006143523 fq.gz 172.1 MB
EGAF00006143528 fq.gz 147.5 MB
EGAF00006143529 fq.gz 142.0 MB
EGAF00006143532 fq.gz 421.5 MB
EGAF00006143533 fq.gz 407.8 MB
EGAF00006143534 fq.gz 352.6 MB
EGAF00006143535 fq.gz 324.7 MB
EGAF00006143536 fq.gz 273.5 MB
EGAF00006143537 fq.gz 263.3 MB
EGAF00006143538 fq.gz 187.1 MB
EGAF00006143539 fq.gz 175.4 MB
EGAF00006143540 fq.gz 701.1 MB
EGAF00006143541 fq.gz 652.6 MB
EGAF00006143542 fq.gz 188.9 MB
EGAF00006143543 fq.gz 174.9 MB
EGAF00006143544 fq.gz 409.8 MB
EGAF00006143545 fq.gz 383.6 MB
EGAF00006143546 fq.gz 411.1 MB
EGAF00006143547 fq.gz 369.9 MB
EGAF00006143548 fq.gz 610.7 MB
EGAF00006143549 fq.gz 559.5 MB
EGAF00006143550 fq.gz 127.0 MB
EGAF00006143551 fq.gz 118.9 MB
EGAF00006143552 fastq.gz 244.3 MB
EGAF00006143553 fastq.gz 263.3 MB
EGAF00006143554 fastq.gz 33.2 MB
EGAF00006143555 fastq.gz 36.0 MB
EGAF00006143556 fq.gz 159.0 MB
EGAF00006143557 fq.gz 146.7 MB
EGAF00006143558 fq.gz 135.3 MB
EGAF00006143559 fq.gz 126.7 MB
EGAF00006143560 fq.gz 656.5 MB
EGAF00006143561 fq.gz 624.5 MB
EGAF00006143566 fq.gz 213.6 MB
EGAF00006143567 fq.gz 196.9 MB
EGAF00006143570 fq.gz 143.0 MB
EGAF00006143571 fq.gz 155.7 MB
EGAF00006143572 fq.gz 262.8 MB
EGAF00006143573 fq.gz 241.6 MB
EGAF00006143574 fq.gz 264.1 MB
EGAF00006143575 fq.gz 256.5 MB
EGAF00006143576 fq.gz 584.1 MB
EGAF00006143577 fq.gz 557.9 MB
EGAF00006143578 fq.gz 801.3 MB
EGAF00006143579 fq.gz 751.0 MB
EGAF00006143580 fq.gz 420.3 MB
EGAF00006143581 fq.gz 392.1 MB
EGAF00006143582 fq.gz 625.2 MB
EGAF00006143583 fq.gz 579.7 MB
EGAF00006143584 fq.gz 231.5 MB
EGAF00006143585 fq.gz 217.2 MB
EGAF00006143588 fastq.gz 261.2 MB
EGAF00006143589 fastq.gz 285.6 MB
EGAF00006143592 fq.gz 264.3 MB
EGAF00006143593 fq.gz 244.1 MB
EGAF00006143596 fq.gz 257.4 MB
EGAF00006143597 fq.gz 254.6 MB
EGAF00006143598 fq.gz 373.1 MB
EGAF00006143599 fq.gz 342.5 MB
EGAF00006143600 fastq.gz 537.5 MB
EGAF00006143601 fastq.gz 579.1 MB
EGAF00006143602 fq.gz 276.2 MB
EGAF00006143603 fq.gz 257.2 MB
EGAF00006143604 fastq.gz 175.9 MB
EGAF00006143605 fastq.gz 186.0 MB
EGAF00006143606 fq.gz 779.4 MB
EGAF00006143607 fq.gz 728.5 MB
EGAF00006143608 fastq.gz 272.0 MB
EGAF00006143609 fastq.gz 287.4 MB
EGAF00006143610 fq.gz 196.1 MB
EGAF00006143611 fq.gz 184.1 MB
EGAF00006143612 fq.gz 754.4 MB
EGAF00006143613 fq.gz 712.6 MB
EGAF00006143614 fq.gz 157.8 MB
EGAF00006143615 fq.gz 151.3 MB
EGAF00006143616 fq.gz 94.7 MB
EGAF00006143617 fq.gz 91.1 MB
EGAF00006143618 fq.gz 422.7 MB
EGAF00006143619 fq.gz 416.7 MB
EGAF00006143620 fq.gz 344.2 MB
EGAF00006143621 fq.gz 321.4 MB
EGAF00006143622 fq.gz 276.0 MB
EGAF00006143623 fq.gz 255.7 MB
EGAF00006143624 fq.gz 352.9 MB
EGAF00006143625 fq.gz 322.8 MB
EGAF00006143626 fq.gz 304.0 MB
EGAF00006143627 fq.gz 280.3 MB
EGAF00006143628 fq.gz 276.8 MB
EGAF00006143629 fq.gz 255.5 MB
EGAF00006143630 fastq.gz 148.3 MB
EGAF00006143631 fastq.gz 163.7 MB
EGAF00006143632 fq.gz 379.8 MB
EGAF00006143633 fq.gz 358.2 MB
EGAF00006143634 fq.gz 828.7 MB
EGAF00006143635 fq.gz 765.0 MB
EGAF00006143636 fq.gz 92.0 MB
EGAF00006143637 fq.gz 88.6 MB
EGAF00006143640 fastq.gz 72.3 MB
EGAF00006143641 fastq.gz 77.0 MB
EGAF00006143642 fastq.gz 165.0 MB
EGAF00006143643 fastq.gz 175.3 MB
EGAF00006143644 fastq.gz 301.0 MB
EGAF00006143645 fastq.gz 325.1 MB
EGAF00006143652 fq.gz 1.3 GB
EGAF00006143653 fq.gz 1.2 GB
EGAF00006143654 fq.gz 211.1 MB
EGAF00006143655 fq.gz 196.2 MB
EGAF00006143656 fq.gz 263.0 MB
EGAF00006143657 fq.gz 246.2 MB
EGAF00006143664 fq.gz 354.5 MB
EGAF00006143665 fq.gz 324.7 MB
EGAF00006143666 fq.gz 373.8 MB
EGAF00006143667 fq.gz 344.6 MB
EGAF00006143668 fastq.gz 90.1 MB
EGAF00006143669 fastq.gz 98.8 MB
EGAF00006143670 fq.gz 224.5 MB
EGAF00006143671 fq.gz 210.0 MB
EGAF00006143672 fq.gz 338.2 MB
EGAF00006143673 fq.gz 308.2 MB
EGAF00006143674 fastq.gz 394.5 MB
EGAF00006143675 fastq.gz 431.7 MB
EGAF00006143676 fastq.gz 231.2 MB
EGAF00006143677 fastq.gz 246.2 MB
EGAF00006143678 fastq.gz 173.5 MB
EGAF00006143679 fastq.gz 200.4 MB
158 Files (49.5 GB)